Bharat Biotech's COVID-19 vaccine COVAXIN first vaccine got approval from DCGI, INDIA

BHARAT BIOTECH COVID-19 VACCINE COVAXIN

The Drug Controller General of India (DCGI) on June 29 granted permission to Bharat Biotech to initiate Phase I and II human clinical trials of its novel coronavirus, or COVID-19 vaccine.

The permission to conduct human trials was granted after the company submitted results generated from pre-clinical studies, demonstrating safety and immune response.

Drug Controller General of India Dr V G Somani approved Bharat Biotech’s application to conduct phase I and II clinical trials for Covaxin, it stated in a release.

"Results from these studies have been promising and show extensive safety and effective immune responses," the management said.

Human clinical trials are scheduled to start across India in July.

By-Amaresh Debata